High-dose Vitamin C enhances cancer immunotherapy
By A. Magri, G. Germano, A. Lorenzato, S. Lamba, R. Chila, M. Montone, V. Amodio, T. Ceruti, F. Sassi, S. Arena, S. Abrignani, D&apos, M. Zucchetti, F. Di Nicolantonio, A. Bardelli and Co-Last And Corresponding Authors
Topics:
PD-1 BLOCKADE, SOLID TUMORS, ASCORBATE, CELLS, DEMETHYLATION, CHEMOTHERAPY, STABILITY, NIVOLUMAB, VITAMIN C, IMMUNOTHERAPY
Publisher: 'American Association for the Advancement of Science (AAAS)'
Year: 2020
DOI identifier: 10.1126/scitranslmed.aay8707
OAI identifier:
oai:iris.unito.it:2318/1740384
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the
following location(s):
http://hdl.handle.net/2318/174... (external
link)
https://stm.sciencemag.org/con... (external
link)